- Exchange: NASDAQ GS
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharma
Aegerion Pharmaceuticals Inc+ Add to Watchlist
AEGR:US25.2200 USD 0.8300 3.19%
As of 20:10:00 ET on 04/17/2015.
Company Profile for Aegerion Pharmaceuticals Inc (AEGR)
Aegerion Pharmaceuticals, Inc. is a biopharmaceutical company. The Company researches small-molecule therapeutics for cardiovascular and metabolic disease. Aegerion's product candidates limit secretion of cholesterol and triglycerides.
Aegerion Pharmaceuticals Inc
Key Executives for Aegerion Pharmaceuticals Inc (AEGR)
|Marc D BeerChief Executive Officer||Mark J FitzpatrickChief Financial Officer|
|Craig FraserChief Operating Officer||Mark SumerayChief Medical Officer|
|Carolina AlarcoPresident:International||Martha J CarterSenior VP/Chief Regulatory|
|Anne Marie CookSenior VP/Secretary/Gen Cnsl|